Form 4: Ceribell Director Sells Shares Under 10b5-1 Plan
Insider Transaction Report
Ceribell Director Josef Parvizi sold 8,286 shares of common stock for $20 per share under a pre-arranged trading plan.
Summary
- Josef Parvizi, a Director and 10% Owner of Ceribell, Inc. (CBLL), sold a total of 8,286 shares of common stock.
- The sales occurred on February 17, 2026, involving 1,300 shares, and on February 18, 2026, involving 6,986 shares.
- The shares were sold at a price of $20 per share, with the second transaction's price being a weighted average ranging from $20 to $20.02.
- These transactions were executed pursuant to a Rule 10b5-1 trading plan adopted by Mr. Parvizi on August 18, 2025.
- Following these transactions, Mr. Parvizi's indirect beneficial ownership includes 739,366 shares via the Josef Parvizi Trust, 907,911 shares via the Innovation ACP Trust, and 369,088 shares via the ACP 2021 Trust.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event. The sale was pre-planned under Rule 10b5-1, indicating a scheduled transaction rather than a reaction to new information, thus having limited immediate implications for company sentiment.
Future Outlook
No specific future outlook or guidance is provided in this Form 4 filing, as it primarily reports an insider transaction.
Industry Context
StockSavvy.ai notes that insider sales executed under Rule 10b5-1 plans are common and often pre-scheduled, reducing the immediate signal of a director's sentiment compared to open market sales without such a plan. These transactions are part of routine portfolio management for executives and are standard disclosures in the industry.
Comparison to Industry Standards
- Form 4 filings are standard regulatory disclosures for insider transactions across all publicly traded companies in the U.S. There are no specific comparable companies or projects for this type of routine disclosure, as it pertains to individual insider trading activity.
Related Party Transactions
- The reported sales were conducted by Josef Parvizi, a Director and 10% Owner of Ceribell, Inc., making these transactions related party dealings. The beneficial ownership is held through trusts where Mr. Parvizi is a trustee or co-trustee.
Stakeholder Impact
- Shareholders: Disclosure of a director's stock sale provides transparency regarding insider holdings and transactions, which can influence investor perception of management's confidence in the company. However, sales under a 10b5-1 plan are generally viewed as less impactful than unscheduled sales.
Key Dates
| Date | Description |
|---|---|
| 08/18/2025 | Rule 10b5-1 trading plan adopted by Josef Parvizi. |
| 02/17/2026 | Sale of 1,300 shares of Common Stock by Josef Parvizi. |
| 02/18/2026 | Sale of 6,986 shares of Common Stock by Josef Parvizi. |
| 02/19/2026 | Date of filing of the Form 4. |
Recommendation
holdThe sale by Director Josef Parvizi was executed under a pre-arranged Rule 10b5-1 trading plan, adopted well in advance of the transaction dates. Such planned sales are often for personal financial management and do not typically signal a change in the company's fundamental outlook or warrant an immediate shift in investment strategy. Therefore, a 'hold' recommendation is appropriate as this filing alone does not provide new information to alter an existing investment thesis.
Keywords
Ceribell, CBLL, Josef Parvizi, Insider Sale, Form 4, Director, 10b5-1 Plan, Stock Transaction, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.